An Open-Label, Multiple-Dosing, Crossover, and Parallel Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers.

Trial Profile

An Open-Label, Multiple-Dosing, Crossover, and Parallel Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Fimasartan; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 20 Sep 2011 Results published in the Journal of Cardiovascular Pharmacology.
    • 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top